Incorporating Lung Diffusing Capacity for Carbon Monoxide in Clinical Decision Making in Chest Medicine - 09/05/19
, Danilo C. Berton, MD, PhD b, Paulo T. Muller, MD, PhD c, Denis E. O’Donnell, MD, FRCPI, FRCPC, FERS dRésumé |
Lung diffusing capacity for carbon monoxide (Dlco) remains the only noninvasive pulmonary function test to provide an integrated picture of gas exchange efficiency in human lungs. Due to its critical dependence on the accessible “alveolar” volume (Va), there remains substantial misunderstanding on the interpretation of Dlco and the diffusion coefficient (Dlco/Va ratio, Kco). This article presents the physiologic and methodologic foundations of Dlco measurement. A clinically friendly approach for Dlco interpretation that takes those caveats into consideration is outlined. The clinical scenarios in which Dlco can effectively assist the chest physician are discussed and illustrative clinical cases are presented.
Le texte complet de cet article est disponible en PDF.Keywords : Lung function, Lung diffusing capacity, Gas exchange, Dyspnea, Hypoxia
Plan
| Disclosure Statement: No author has any relationship with a commercial company that has a direct financial interest in the subject matter or materials discussed in this article or with a company making a competing product. |
Vol 40 - N° 2
P. 285-305 - juin 2019 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
